The present disclosure provides novel variants of enzymes exhibiting serine protease activity nucleic acid molecules encoding said proteases, vectors, host cells containing the nucleic acids and methods for preparation and producing such enzymes compositions and complexes comprising at least one of the proteases and methods for using such enzymes as a part of an immunoprotease, in particular for the treatment of cancer.
